Edition:
India

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

339.10INR
10:19am IST
Change (% chg)

Rs-1.40 (-0.41%)
Prev Close
Rs340.50
Open
Rs338.95
Day's High
Rs342.95
Day's Low
Rs337.00
Volume
18,411
Avg. Vol
31,403
52-wk High
Rs548.90
52-wk Low
Rs322.90

Latest Key Developments (Source: Significant Developments)

Shilpa Medicare Gets USFDA Final Approval For Its ANDA, Docetaxel Injection
Friday, 17 May 2019 

May 17 (Reuters) - Shilpa Medicare Ltd ::SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, DOCETAXEL INJECTION.  Full Article

Shilpa Medicare Gets U.S. FDA Final Nod For ANDA, Zoledronic Acid Injection
Thursday, 16 May 2019 

May 16 (Reuters) - Shilpa Medicare Ltd ::RECEIVED U.S. FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, ZOLEDRONIC ACID INJECTION, 4 MG/5 ML.  Full Article

Shilpa Medicare Gets U.S. FDA Tentative Nod For ANDA, Bortezomid For Injection, 3.5Mg/Vial
Tuesday, 9 Apr 2019 

April 9 (Reuters) - Shilpa Medicare Ltd ::GETS U.S. FDA TENTATIVE APPROVAL FOR ITS ANDA, BORTEZOMID FOR INJECTION, 3.5MG/VIAL.  Full Article

India's Shilpa Medicare Sept-Qtr Consol Net Profit Rises
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Shilpa Medicare Ltd ::SEPT QUARTER CONSOL NET PROFIT 422.7 MILLION RUPEES VERSUS PROFIT 341.5 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 1.62 BILLION RUPEES VERSUS 2.04 BILLION RUPEES YEAR AGO.  Full Article

India's Shilpa Medicare March Quarter Consol Profit Falls
Monday, 28 May 2018 

May 28 (Reuters) - Shilpa Medicare Ltd ::MARCH QUARTER CONSOL PROFIT 306.4 MILLION RUPEES VERSUS PROFIT 373.3 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.34 BILLION RUPEES VERSUS 2.26 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets EU-GMP Certification From AGES For 2 API Manufacturing Plants, Formulation Facility
Monday, 23 Apr 2018 

April 23 (Reuters) - Shilpa Medicare Ltd ::GOT EU-GMP CERTIFICATION FROM AUSTRIAN AGENCY AGES FOR 2 API MANUFACTURING PLANTS IN KARNATAKA,FORMULATION FACILITY IN TELANGANA.AUSTRIAN AGENCY AGES CARRIED OUT AUDIT OF API PLANTS BETWEEN JAN 16-24 AND FORMULATION FACILITY BETWEEN JAN 25-31.  Full Article

India's Shilpa Medicare ‍Declared Interim Dividend Of 0.70 Rupees Per Shr
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - Shilpa Medicare Ltd ::‍DECLARED INTERIM DIVIDEND OF 0.70 RUPEES PER EQUITY SHARE​.  Full Article

India's Shilpa Medicare Dec-Qtr Consol Profit Falls
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Shilpa Medicare Ltd ::DEC QUARTER CONSOL PROFIT 163.4 MILLION RUPEES VERSUS PROFIT OF 170.5 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.86 BILLION RUPEES VERSUS 1.84 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets 483 Observations From U.S. FDA For SEZ Formulation Facilities In Telangana
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Shilpa Medicare Ltd ::SAYS GOT 483 OBSERVATIONS FROM U.S. FDA IN RELATION TO SEZ FORMULATION FACILITIES SITUATED AT JADCHERLA, TELANGANA.SAYS TOTAL 10 OBSERVATIONS WERE CITED DURING CLOSE UP MEETING.SAYS 7 OBSERVATIONS ARE IMPROVEMENT IN PROCEDURES AND PRACTICES.SAYS 3 OBSERVATIONS RELATED TO SETTING OF ANALYTICAL SPECIFICATIONS, TEST PROCEDURES, METHOD VALIDATION.  Full Article

India's Shilpa Medicare Sept-qtr profit rises
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Shilpa Medicare Ltd ::Sept quarter profit 481.9 million rupees versus 331.9 million rupees year ago.Sept quarter revenue from operations 1.94 billion rupees versus 1.96 billion rupees year ago.  Full Article

RPT-ICRA ratings for Indian debt instruments-Mar 25

(Repeating to add more ratings.) Mar 25 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of March 22, 2019. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ---------------